Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen R Bloom

Showing results (121-130 of 252) with videos related to

Pageof 26
Sort By:
Endocrinology|April 1, 2006
Neuropeptide S stimulates the hypothalamo-pituitary-adrenal axis and inhibits food intakeKirsty L Smith, Michael Patterson, Waljit S Dhillo, et al.
Regulatory Peptides|October 20, 2004
Abnormalities of the hypothalamo-pituitary-thyroid axis in the pro-opiomelanocortin deficient mouseNiamh M Martin, Caroline J Small, Arshia Sajedi, et al.
Endocrinology|March 6, 2004
Peripheral oxyntomodulin reduces food intake and body weight gain in ratsCatherine L Dakin, Caroline J Small, Rachel L Batterham, et al.
Plos One|March 25, 2016
Proglucagon Promoter Cre-Mediated AMPK Deletion in Mice Increases Circulating GLP-1 Levels and Oral Glucose ToleranceSophie R Sayers, Frank Reimann, Fiona M Gribble, et al.
Diabetes, Obesity & Metabolism|October 5, 2023
Abolishing β-arrestin recruitment is necessary for the full metabolic benefits of G protein-biased glucagon-like peptide-1 receptor agonistsCharlotte E Hinds, Ellie Peace, Shiqian Chen, et al.
Scientific Reports|November 20, 2021
A glucagon analogue decreases body weight in mice via signalling in the liverCharlotte E Hinds, Bryn M Owen, David C D Hope, et al.
Clinical Nutrition (Edinburgh, Scotland)|May 16, 2006
The effect of different macronutrient infusions on appetite, ghrelin and peptide YY in parenterally fed patientsCharles D Murray, Carel W le Roux, Catherine Gouveia, et al.
Brain Research|May 3, 2005
The inhibitory effects of peripheral administration of peptide YY(3-36) and glucagon-like peptide-1 on food intake are attenuated by ablation of the vagal-brainstem-hypothalamic pathwayCaroline R Abbott, Mariana Monteiro, Caroline J Small, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|August 16, 2005
Post-embryonic ablation of AgRP neurons in mice leads to a lean, hypophagic phenotypeGavin A Bewick, James V Gardiner, Waljit S Dhillo, et al.
Diabetes, Obesity & Metabolism|February 19, 2021
Safety and efficacy of an extended-release peptide YY analogue for obesity: A randomized, placebo-controlled, phase 1 trialTricia M-M Tan, James Minnion, Bernard Khoo, et al.
Pageof 26

Showing results (121-130 of 252) with videos related to

Sort By:
Pageof 26
Endocrinology|April 1, 2006
Neuropeptide S stimulates the hypothalamo-pituitary-adrenal axis and inhibits food intakeKirsty L Smith, Michael Patterson, Waljit S Dhillo, et al.
Regulatory Peptides|October 20, 2004
Abnormalities of the hypothalamo-pituitary-thyroid axis in the pro-opiomelanocortin deficient mouseNiamh M Martin, Caroline J Small, Arshia Sajedi, et al.
Endocrinology|March 6, 2004
Peripheral oxyntomodulin reduces food intake and body weight gain in ratsCatherine L Dakin, Caroline J Small, Rachel L Batterham, et al.
Plos One|March 25, 2016
Proglucagon Promoter Cre-Mediated AMPK Deletion in Mice Increases Circulating GLP-1 Levels and Oral Glucose ToleranceSophie R Sayers, Frank Reimann, Fiona M Gribble, et al.
Diabetes, Obesity & Metabolism|October 5, 2023
Abolishing β-arrestin recruitment is necessary for the full metabolic benefits of G protein-biased glucagon-like peptide-1 receptor agonistsCharlotte E Hinds, Ellie Peace, Shiqian Chen, et al.
Scientific Reports|November 20, 2021
A glucagon analogue decreases body weight in mice via signalling in the liverCharlotte E Hinds, Bryn M Owen, David C D Hope, et al.
Clinical Nutrition (Edinburgh, Scotland)|May 16, 2006
The effect of different macronutrient infusions on appetite, ghrelin and peptide YY in parenterally fed patientsCharles D Murray, Carel W le Roux, Catherine Gouveia, et al.
Brain Research|May 3, 2005
The inhibitory effects of peripheral administration of peptide YY(3-36) and glucagon-like peptide-1 on food intake are attenuated by ablation of the vagal-brainstem-hypothalamic pathwayCaroline R Abbott, Mariana Monteiro, Caroline J Small, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|August 16, 2005
Post-embryonic ablation of AgRP neurons in mice leads to a lean, hypophagic phenotypeGavin A Bewick, James V Gardiner, Waljit S Dhillo, et al.
Diabetes, Obesity & Metabolism|February 19, 2021
Safety and efficacy of an extended-release peptide YY analogue for obesity: A randomized, placebo-controlled, phase 1 trialTricia M-M Tan, James Minnion, Bernard Khoo, et al.
Pageof 26